Skip to Main Content
1-877-YALEMDS
SpecialistsFact SheetsDepartmentsClinical TrialsNewsPatient ToolsFor Medical Professionals
1-877-YALEMDS
  • Search
  • Clinical Trials
  • Lymphangioleiomyomatosis (LAM)

Clinical Trials

    • Cancer(2)
    • Heart/Cardiovascular(1)
  • Heart/Cardiovascular

    A Phase 2a Study of LAM-001 for the Treatment of Pulmonary Hypertension

    • Ages18 years and older
    • GenderBoth
  • Gynecological Cancers

    A Phase 3, Randomized, Open-Label Study of Combination Therapy With Avutometinib Plus Defactinib Versus Investigator's Choice of Treatment in Patients With Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) (RAMP 301)

    • GenderFemale only
  • Gynecological Cancers

    A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of Lademirsen (SAR339375) for Subcutaneous Injection Administered Every Week in Patients With Alport Syndrome

    • About Us
    • Contact Us
    • Donate
    • Referring Doctors
    • Clinical Keywords

    333 Cedar St.

    New Haven, CT 06510

    • Yale School of Medicine
    • Yale University
    • Terms & Privacy Policies
    • Accessibility at YSM
    • Patient Rights
    • HIPAA at Yale
    • Non-discrimination Statement
    Copyright 2025 Yale Medicine